Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06722027 · ClinicalTrials.gov registry record · NA

CCSH (Compassion-Centered Spiritual Health) for Teams

A NA study of Health Behavior, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06722027: Recruiting NA study of Health Behavior, sponsored by Emory University.

NCT06722027 is a NA study of Health Behavior that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 2,185-participant average among 65 other Health Behavior trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06722027, a NA study of Health Behavior, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

Emory Spiritual Health has developed a Compassion-Centered Spiritual Health group-based intervention, called CCSH Interventions for Teams, and are enrolling staff and providers into the groups in this randomized study design. The groups will meet once every other week for 60 minutes for 8 weeks (4 sessions total). The investigators will evaluate the feasibility and acceptability of this novel team-based intervention that includes mindfulness and compassion-based approaches with mixed-role oncology teams. Employees (n = 80; nurses, advanced practice providers (APPs), physicians, staff) working at an NCI- designated Comprehensive Cancer Center will be randomized by team (8-12 employees/group) to Compassion Centered Spiritual Health Team Intervention (CCSH-TI) or TAU (Treatment as Usual) group. The research objective is to evaluate the feasibility and acceptability of CCSH-TI, and to develop and validate a novel, low-burden ambulatory assessment "toolkit" to improve the measurement of psychological safety and burnout.

Primary Outcome

Proportion of eligible employees (all, and according to license, sex/gender, race/ethnicity) who enroll and are willing to be randomized.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Compassion Centered Spiritual Health Team Intervention (CCSH-TI)

Study Locations (2)

Georgia

  • Emory Winship Cancer Institute - Atlanta
  • Emory University St. Joseph hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-09-24
Est. Completion 2026-11-01
Phase NA
Emory University

1,208 total trials

What NCT06722027 shows while recruiting

NCT06722027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,185-participant average among 65 other Health Behavior trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Health Behavior appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT06722027 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06722027 about?

NCT06722027 is a clinical study titled "CCSH (Compassion-Centered Spiritual Health) for Teams". Emory Spiritual Health has developed a Compassion-Centered Spiritual Health group-based intervention, called CCSH Interventions for Teams, and are enrolling staff and providers into the groups in this randomized study design. The groups will meet once every other week for 60 minutes for 8 weeks (4 s...

What is the current status of trial NCT06722027?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-09-24. Estimated completion is 2026-11-01.

What conditions does trial NCT06722027 study?

This clinical trial studies the following conditions: Health Behavior.

What interventions are being tested in trial NCT06722027?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Compassion Centered Spiritual Health Team Intervention (CCSH-TI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06722027?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06722027 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Behavior

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06722027's enrollment target sits among peer trials

80 51st of 65 higher than 14 of 65 other Health Behavior trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06722027, the US trial registry maintained by the National Library of Medicine. NCT06722027 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.